How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
New Delhi, Jul 31 (PTI) India's leading pharmaceutical company Ranbaxy Laboratories has initiated the process to file its Anti Retro Viral (ARV) products with the US Food and Drug Administration (USFDA) with first filing likely before this year end.
The filing would take place under the expedited review process...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
